Sort by
Refine Your Search
-
Listed
-
Employer
-
Field
-
Department of Pathology and Molecular Pathology Non-Tenure Track Assistant Professorship of Computational Functional Tumor Pathology 100% Start of employment by agreement, temporay The Faculty
-
100%, Zurich, fixed-term The Technology Marketing Group , founded by Florian von Wangenheim in 2013, is a pioneering research group at ETH Zurich dedicated to exploring the intersection of marketing
-
well as metabolic, neurodegenerative, autoimmune, and infectious diseases. Job description Postdoctoral projects will combine catalyst engineering, computational simulation, bioelectrode device fabrication, and
-
well as metabolic, neurodegenerative, autoimmune, and infectious diseases. Job description PhD projects will combine catalyst engineering, computational simulation, bioelectrode device fabrication, and electrical
-
, Switzerland [map ] Subject Areas: Computer Science / Distributed Systems and Networking , Networking , Networking and distributed systems Appl Deadline: 2026/01/08 11:59PM (posted 2025/11/10, listed until
-
evaluate prototypes together with industrial partners Profile Required experience CH/EU/EFTA citizenship or valid Swiss work permit PhD in Engineering, Computer Science, Robotics, or related field Strong
-
tools. Our group combines biology, engineering, and computational science to understand how cells organize into complex tissues. Located in Basel, the Department of Biosystems Science and Engineering (D
-
or mechanical engineering, or CS Solid knowledge of computer vision and ML, particularly anomaly detection methods Experience with multimodal data (e.g., image + time series, sensor fusion) is a strong ad-vantage
-
, with strong expertise in tissue remodeling and regeneration, molecular oncology, genome engineering, functional genomics, metabolomics, and computational biology, providing an ideal setting for impactful
-
of Medical Microbiology at the University of Zurich, the Department of Informatics at ETHZ and several further partners, we address the challenge by the combining microfluidic technology, sequencing and fast